1. Home
  2. SAGE vs SEI Comparison

SAGE vs SEI Comparison

Compare SAGE & SEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • SEI
  • Stock Information
  • Founded
  • SAGE 2010
  • SEI 2014
  • Country
  • SAGE United States
  • SEI United States
  • Employees
  • SAGE N/A
  • SEI N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • SEI
  • Sector
  • SAGE Health Care
  • SEI
  • Exchange
  • SAGE Nasdaq
  • SEI NYSE
  • Market Cap
  • SAGE 571.7M
  • SEI 681.1M
  • IPO Year
  • SAGE 2014
  • SEI 2017
  • Fundamental
  • Price
  • SAGE $9.08
  • SEI $31.67
  • Analyst Decision
  • SAGE Hold
  • SEI Strong Buy
  • Analyst Count
  • SAGE 18
  • SEI 8
  • Target Price
  • SAGE $10.06
  • SEI $43.71
  • AVG Volume (30 Days)
  • SAGE 2.8M
  • SEI 1.6M
  • Earning Date
  • SAGE 07-30-2025
  • SEI 08-16-2025
  • Dividend Yield
  • SAGE N/A
  • SEI 1.52%
  • EPS Growth
  • SAGE N/A
  • SEI N/A
  • EPS
  • SAGE N/A
  • SEI 0.50
  • Revenue
  • SAGE $47,404,000.00
  • SEI $371,533,000.00
  • Revenue This Year
  • SAGE $102.21
  • SEI $65.83
  • Revenue Next Year
  • SAGE $43.01
  • SEI $35.50
  • P/E Ratio
  • SAGE N/A
  • SEI $62.88
  • Revenue Growth
  • SAGE N/A
  • SEI 33.59
  • 52 Week Low
  • SAGE $4.62
  • SEI $8.24
  • 52 Week High
  • SAGE $13.47
  • SEI $39.03
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 71.54
  • SEI N/A
  • Support Level
  • SAGE $9.04
  • SEI N/A
  • Resistance Level
  • SAGE $9.30
  • SEI N/A
  • Average True Range (ATR)
  • SAGE 0.15
  • SEI 0.00
  • MACD
  • SAGE 0.05
  • SEI 0.00
  • Stochastic Oscillator
  • SAGE 91.35
  • SEI 0.00

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About SEI SOLARIS ENERGY INFRASTRUCTURE INC

Solaris Energy Infrastructure Inc provides services in the oil and gas industry. Its solutions are Solaris software suite, Fluid management system, Automated control systems, Field services, Last mile management, Wet sand solutions, Power Solutions, and Integrated wellsite solution. Its segment include Solaris Power Solutions and Solaris Logistics Solutions. It derives maximum revenue from Solaris Logistics Solutions segment.

Share on Social Networks: